Colorectal Cancer Clinical Trials in North Carolina

Showing 161-172 of 172 trials

Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia

NCT00005809

RATIONALE: New diagnostic procedures such as computed tomographic colonography may provide a less invasive method of identifying patients who have colorectal neoplasia. PURPOSE: Diagnostic study to compare the effectiveness of computerized tomographic colonography with that of standard diagnostic procedures in detecting colorectal neoplasia.

Colorectal Cancer

American College of Radiology Imaging NetworkStarted Jul 2000

Birmingham, Alabama, United States • Los Angeles, California, United States • San Francisco, California, United States +8 more locations

COMPLETEDPHASE246 miles

Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer

NCT00707889

To determine the effect of ABT-869 plus mFOLFOX6 compared to bevacizumab plus mFOLFOX6 on disease progression in advanced colorectal cancer.

Advanced Colorectal CancerAdenocarcinoma of the ColonAdenocarcinoma of the Rectum

AbbVie (prior sponsor, Abbott)159 participantsStarted Oct 2008

Chapel Hill, North Carolina, United States • Philadelphia, Pennsylvania, United States • Nashville, Tennessee, United States +43 more locations

Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia

Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer

Colorectal Cancer Trials in Other Cities

Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer

Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants

Study of XL281 in Adults With Solid Tumors

GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer

Other Conditions in North Carolina